Regular laboratory monitoring every four to six weeks for six months to 12

Regular laboratory monitoring every four to six weeks

This preview shows page 4 - 6 out of 6 pages.

Regular laboratory monitoring every four to six weeks for six months to 12 months is also recommended to determine spontaneous clearance of HCV infection versus persistence of infection (Drugs.com, 2017).HL’s symptomology and presentation it is my belief the patient can be classified as genotype1a (without cirrhosis) (Drugs.com, 2017). Guidelines for the diagnosis and management of HCV
Background image
infection were originally released jointly by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) in 2016 and are updated on a continuous basis, following availability of new medications or release of major treatment trials. Regimen selection for patients with genotype 1 infection should take into account the efficacy, duration, and adverse reactions, potential drug interactions, the patient's history of prior treatment, and the stage of fibrosis before selecting the best medication to treat (Arcangelo & Peterson, 2013) References:Arcangelo, V. P., & Peterson, A. M. (2013). Pharmacotherapeutics for Advanced Practice: A practical approach.Ambler, PA: Lippincott Williams and Wilkins.American Association for the Study of Liver Diseases and the Infectious Diseases Society of America (2016). Management of Acute HCV Infection. Retrieved July 9, 2018 from Centers for Disease Control and Prevention (2016). Hepatitis C FAQs for the Public. Retrieved July 9, 2018 from
Background image
Hypertension if left without treatment can causes nausea and vomiting as presenting symptoms. This nausea and vomiting can also be a sign of a heart attack a comprehensive lab work-up to ensure there is no damage to the heart must be complete for the visit to be thorough in diagnosing and treatment. Multiple or continuous blood pressure measurements should be ordered if they could be responsible for the symptoms.Arcangelo, V. P., & Peterson, A. M. (2013). Pharmacotherapeutics for Advanced Practice: A practical approach.Ambler, PA: Lippincott Williams and Wilkins.
Background image

You've reached the end of your free preview.

Want to read all 6 pages?

  • Spring '16
  • Prednisone, Hepatitis C, Hepatitis C. HL

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture